Diskussionsleiter: A. Götte (Paderborn)
(P408) | Loss of TBX5 leads to ventricular arrhythmias | |
F. Rathjens, A. Renger, L. M. Iyer, C. Noack, F. Syeda, M. Dewenter, A. El-Armouche, L. Fabritz, W.-H. Zimmermann, L. Zelarayán, M. P. Zafeiriou (Göttingen, Regensburg, Dresden; Birmingham, UK) | ||
(P409) | Pressure overload aggravates cardiac dysfunction and malignant arrhythmias in desmin-related cardiomyopathies | |
F. Stöckigt, L. Eichhorn, T. Beiert, C. Clemen, R. Schröder, G. Nickenig, J. W. Schrickel (Bonn, Köln, Erlangen) | ||
(P410) | Transient activation of cytoplasmic Akt causes cardiac arrhythmia | |
R. Klocke, L. Fabritz, L. Fortmüller, K. Walsh, S. Nikol, F. U. Müller, J. Waltenberger, P. Kirchhof, P. Boknik (Münster; Birmingham, UK; Boston, US) | ||
(P411) | Inhibition of neuronal Na channel NaV1.8 reduces INaL and SR-Ca leak in failing human and mouse ventricular cardiomyocytes. | |
S. Ahmad, P. Tirilomis, P. Bengel, N. Dybkova, G. Hasenfuß, N. Frey, S. T. Sossalla (Göttingen, Kiel) | ||
(P412) | Mechanisms of increased ventricular arrhythmia susceptibility in type 2 diabetic mice | |
C. Jungen, P. Rajendran, S. Willems, C. Meyer, J. Tompkins (Hamburg; Los Angeles, US) | ||
(P413) | Cellular Mechanisms of the Anti-Arrhythmic Effect of Cardiac PDE2 Overexpression | |
K. Richter, N. Dybkova, C. Vettel, M. Dewenter, F. Mason, T. Wieland, R. Fischmeister, A. El-Armouche, S. T. Sossalla, M. Wagner (Dresden, Göttingen, Mannheim, Heidelberg, Kiel; Châtenay-Malabry Cedex, FR) |